SOST and sclerosteosis: The role of sclerostin in the modulation of the Wnt/β-catenin dependent pathway came to light specifically through the study of sclerosteosis and van Buchem disease, two rare genetic disorders associated with high levels of BMD and an associated low risk of fracture [14].